Enhancing Scale-Up, Increasing Quality, and Reducing Costs for AVs, LVVs, AAVs and More The 3rd Viral Vector Process Development and Manufacturing Summit returns to Boston, uniting industry leaders ...

Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Manufacturing Markets and Technologies Through 2030" report has been added to ResearchAndMarkets.com's offering. The global market for viral ...

North America dominated the viral vector & plasmid DNA manufacturing market with a revenue share in 2024. Asia Pacific is expected to grow at the fastest CAGR in the market during the forecast period.

Cell and gene therapies offer hope for previously untreatable diseases, with viral vectors currently favored as the primary gene delivery method. To meet patient needs, reliable and cost-effective ...

The global viral vector manufacturing market is projected to expand at a robust CAGR of approximately 20% over the forecast period, supported by multiple transformative forces reshaping the ...

Cell and gene therapies offer hope for previously untreatable diseases, with viral vectors currently favored as the primary gene delivery method. To meet patient needs, reliable and cost-effective ...

PHILADELPHIA--(BUSINESS WIRE)--VintaBio, a biotech manufacturing technology company specializing in high-yield, high-purity viral vector production for reliable gene therapy access, will present ...

Dublin, July 09, 2025 (GLOBE NEWSWIRE) -- The "Viral Vectors & Plasmid DNA Manufacturing Market Report 2025-2035" has been added to ResearchAndMarkets.com's offering. The global Viral Vectors and ...

The nanofiber microcarriers are the first of their kind for manufacturing viral vectors used in gene therapy production, according to Cellevate. Sweden-based biotech company, Cellevate, which ...